Scholars Central

Conference abstract

Prevalence of complications in patients with aplastic anemia using the standard treatment protocol

Authors: I.V. Berger, A.D. Makhmudova

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

During the last 3 years, new data on the therapy of aplastic anemia (AA) with standard treatment protocols have been obtained. In the treatment of patients, AA severity criteria developed by the International Study Group AA are still widely used, which have prognostic value and allow comparison of the treatment methods of patients with similar severity of the disease. Retrospectively, 85 case histories for the period 2013-2015 were analyzed and the most frequent complications of AA were identified. Women made up 41% (35 people), men - 59% (50). The prevalence of patients aged 18 to 36 years, living in Andijan -27% (23 people), Fergana-21% (18 patients), Surkhandarya -13% (11 people), in other areas from 1 to 5%. Age characteristics are presented in the table. According to the international classification of AA, all patients in severity were divided into groups with severe - 58% and non-severe - 42%. In all patients, the diagnosis of AA was confirmed by the results of the myelogram, which showed a decrease in the cellularity of the bone sprout, a predominance of lymphocytes and adipose tissue, and was also confirmed by the study of the cytokine status of patients such as erythropoietin, tumor necrosis factor, interleukins 1,4,6,8. In the treatment of patients according to standard protocols, mainly glucocorticosteroid used 65%, in a dose of 8 to 20 mg of dexamethasone and from 30 to 90 mg of prednisolone in combination with a hemocomponent correction. Cyclosporine A at a dose of 5 mg/kg, together with substitution therapy was used in 48% of cases. Splenectomy was performed in 26% of cases. Conclusion: Thus, the analysis of the occurring complications has shown that the greatest effectiveness and the least number of complications is the use of immunosuppressive therapy with Cyclosporin A. In non-severe form of AA, glucocorticosteroids can be used. The use of splenectomy gave a small% of complications, but also did not show the results of the cure, the patients had to subsequently take glucocorticoid therapy.

Subjects

Haematology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Blood Disorders & Transfusion.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Blood Disorders & Transfusion
  • SubjectHaematology
  • BylineArticles whose byline prints “I.V. Berger”
  • BylineArticles whose byline prints “A.D. Makhmudova”